Importance of synovial fluid aspiration when injecting intra-articular corticosteroids.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 10700435.
- Also identified by PMC identifier 1753098.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The aim of this prospective study was to find if a complete synovial fluid aspiration before injecting intra-articular corticosteroids influences the treatment result. The study was performed in 147 patients with rheumatoid arthritis (RA). One hundred and ninety one knees with synovitis were randomised to arthrocentesis (n=95) or no arthrocentesis (n = 96) before 20 mg triamcinolone hexacetonide was injected. The duration of effect was followed up for a period of six months. All patients were instructed to contact the rheumatology department if signs and symptoms from the treated knee recurred. If arthritis could be confirmed by a clinical examination a relapse was noted. There was a significant reduction of relapse in the arthrocentesis group (p = 0.001). The study shows that aspiration of synovial fluid can reduce the risk for arthritis relapse when treating RA patients with intra-articular corticosteroids. It is concluded that arthrocentesis shall be included in the intra-articular corticosteroid injection procedure.
Medical subject headings
- Anti-Inflammatory Agents
- Arthritis, Rheumatoid
- Knee Joint
- Synovial Fluid
- Triamcinolone Acetonide